Seven years of published research, registered trials, and longitudinal outcomes.
Published in the American Journal of Gastroenterology (2025): 81% of participants in a gut-directed hypnotherapy program met the IBS-SSS responder threshold at 6 weeks, compared with 63% on active control (n=244).1 Published in JMIR Formative Research (2025): 76% of participants in a clinical hypnotherapy program reported ≥50% reduction in daily hot flashes (n=139). Persistent benefit at follow-up across both cohorts. Results from peer-reviewed studies; individual outcomes vary.
| Program | Endpoint | Effect | Comparator / cohort | Source |
|---|---|---|---|---|
| Nerva | IBS-SSS reduction ≥50 pts at 6wk | 81% | vs. 63% active control | Anderson, AJG 2025 |
| Nerva | Abdominal pain severity reduction | 71% | vs. 35% active control | Anderson, AJG 2025 |
| Nerva | Quality of life increase | +28% | AJG cohort | Anderson, AJG 2025 |
| Evia | ≥50% reduction in daily hot flashes | 76% | real-world cohort | Scheffrahn, JMIR 2025 |
| Hypnosis (clinical) | Avg pain reduction vs. control (meta-analysis) | 79% | 19 RCTs | Milling, 2021 meta-analysis |
The American Journal of Gastroenterology · 120(2):440-448
JMIR Formative Research · 2025;9:e63948
Neurogastroenterology & Motility · Real-world Nerva user cohort
International Journal of Clinical and Experimental Hypnosis · 42 trials reviewed; 19 with robust methodology
The Journal of Pain · RCT · pain reduction doubled vs. education alone
Alimentary Pharmacology & Therapeutics · 44(5):447-459 · founding-protocol RCT
Menopause: The Journal of The Menopause Society · Foundational Evia protocol RCT
Gut-directed hypnotherapy beyond IBS. Bloating, distension, and upper GI symptoms in adults with disorders of gut-brain interaction.
How Mindset programs perform in patients with overlapping conditions. IBS with endometriosis, interstitial cystitis, and inflammatory bowel disease.
Outcomes in populations our published trials have not yet reached. Pregnancy, paediatrics, and underserved cohorts.
Controlled studies inside national health systems and academic referral pathways. Real-world adoption, not just efficacy.
Wearable signals layered onto the Mindset model. Heart rate and sleep used to predict response and time sessions.
Models that match the right program, intensity, and timing to each person, drawing on response data from across the cohort.